title: Comparison of a serotonin antagonist, opioid antagonist, and TRH analog for the acute treatment of experimental spinal trauma.
abstract: The therapeutic efficacies of a serotonin antagonist (mianserin), an opioid antagonist (nalmefene), and a TRH analog (YM-14673) were compared in a well-characterized model of experimental spinal trauma in the rat. Injury was produced by the weight-drop method at T10 and confirmed by the disappearance of the somatosensory evoked response during the subsequent 15 minutes. Drug or vehicle treatments were administered randomly as a single intravenous bolus 15 minutes after injury. Functional outcome was blindly assessed for 2 weeks postinjury using a modified Tarlov scale and the Rivlin-Tator angleboard test. The survival of descending raphe-spinal axons was determined by measurement of serotonin in postmortem spinal tissues located above and below the injury, and histopathologic studies were carried out at the site of injury. All agents displayed similar and significant efficacies with respect to Tarlov and Rivlin-Tator measures of motor recovery and preservation of raphe-spinal fibers below the lesion site. In contrast, none of the agents were effective for preserving the central gray matter or myelin staining in the white matter in slices of tissue from the site of injury. Results are discussed in terms of the early treatment of spinal cord injury and future clinical trials.
authors.affiliation: Alfred I. duPont Institute, Spinal Trauma Research Program, Wilmington, Delaware.
authors.forename: M A
authors.initials: MA
authors.lastname: Puniak
authors.forename: G M
authors.initials: GM
authors.lastname: Freeman
authors.forename: C A
authors.initials: CA
authors.lastname: Agresta
authors.forename: L
authors.initials: L
authors.lastname: Van Newkirk
authors.forename: C A
authors.initials: CA
authors.lastname: Barone
authors.forename: S K
authors.initials: SK
authors.lastname: Salzman
mesh_terms: D000818:Animals; D001384:Azetidines / Q000627:therapeutic use*; D004151:Dipeptides / Q000627:therapeutic use*; D005073:Evoked Potentials, Somatosensory / Q000187:drug effects; D008297:Male; D008803:Mianserin / Q000627:therapeutic use*; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D011379:Prognosis; D051381:Rats; D011919:Rats, Inbred Strains; D013116:Spinal Cord / Q000737:chemistry; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000503:physiopathology; D013973:Thyrotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D001384:Azetidines; D004151:Dipeptides; D009292:Narcotic Antagonists; D008803:Mianserin; D009271:Naltrexone; D013973:Thyrotropin-Releasing Hormone; C054995:azetirelin; C038981:nalmefene